Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit Smoking

PHASE3TerminatedINTERVENTIONAL
Enrollment

257

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

April 30, 2011

Study Completion Date

June 30, 2011

Conditions
Tobacco Dependence
Interventions
DRUG

Placebo

Dosage Form: Oral NRT; Dose: 0 mg; Frequency: up to 4 times per hour; Duration: 12 weeks

DRUG

Nicotine

Dosage Form: Oral NRT; Dose: 1 mg;Frequency: up to four times per hour; Duration:12 weeks

Trial Locations (19)

18015

Family Prescription Center, Bethlehem

23192

Montpelier Pharmacy, Inc., Montpelier

27609

Kerr Drug, Raleigh

30224

Wynn's Pharmacy, Inc., Griffin

35661

Avalon Discount Drugs, Muscle Shoals

38614

Medicap Pharmacy, Clarksdale

38635

Liddy's Health Mart, Holly Springs

55070

Goodrich Pharmacy, Saint Francis

55303

Goodrich Pharmacy, Anoka

55330

Goodrich Pharmacy, Elk River

55426

Cub Pharmacy #1924, Saint Louis Park

64116

Stark Pharmacy, Overland Park

64485

Countryside Pharmacy, Savannah

75602

Louis Morgan Drug #1, Longview

75701

Brick Street Pharmacy, Tyler

76645

T.B. Bond Pharmacy, Hillsboro

77070

Inwood Pharmacy, Houston

87110

Phil's Pills, Albuquerque

92054

Coast Compounding Pharmacy, Oceanside

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

McNeil AB

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

lead

McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.

INDUSTRY